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Summary
Background Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction 
of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less 
than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential 
trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, and Risk 
Factors Study (GBD) 2019 findings for all-cause mortality and cause-specific mortality in children younger than 
5 years of age, with multiple scenarios for child mortality in 2030 that include the consideration of potential effects 
of COVID-19, and a novel framework for quantifying optimal child survival.
Methods We completed all-cause mortality and cause-specific mortality analyses from 204 countries and territories for 
detailed age groups separately, with aggregated mortality probabilities per 1000 livebirths computed for neonatal 
mortality rate (NMR) and under-5 mortality rate (U5MR). Scenarios for 2030 represent different potential trajectories, 
notably including potential effects of the COVID-19 pandemic and the potential impact of improvements preferentially 
targeting neonatal survival. Optimal child survival metrics were developed by age, sex, and cause of death across all 
GBD location-years. The first metric is a global optimum and is based on the lowest observed mortality, and the second 
is a survival potential frontier that is based on stochastic frontier analysis of observed mortality and Healthcare Access 
and Quality Index.
Findings Global U5MR decreased from 71·2 deaths per 1000 livebirths (95% uncertainty interval [UI] 68·3–74·0) in 
2000 to 37·1 (33·2–41·7) in 2019 while global NMR correspondingly declined more slowly from 28·0 deaths per 
1000 live births (26·8–29·5) in 2000 to 17·9 (16·3–19·8) in 2019. In 2019, 136 (67%) of 204 countries had a U5MR 
at or below the SDG 3.2 threshold and 133 (65%) had an NMR at or below the SDG 3.2 threshold, and the reference 
scenario suggests that by 2030, 154 (75%) of all countries could meet the U5MR targets, and 139 (68%) could meet 
the NMR targets. Deaths of children younger than 5 years totalled 9·65 million (95% UI 9·05–10·30) in 2000 
and 5·05 million (4·27–6·02) in 2019, with the neonatal fraction of these deaths increasing from 39% (3·76 million 
[95% UI 3·53–4·02]) in 2000 to 48% (2·42 million; 2·06–2·86) in 2019. NMR and U5MR were generally higher in 
males than in females, although there was no statistically significant difference at the global level. Neonatal 
disorders remained the leading cause of death in children younger than 5 years in 2019, followed by lower 
respiratory infections, diarrhoeal diseases, congenital birth defects, and malaria. The global optimum analysis 
suggests NMR could be reduced to as low as 0·80 (95% UI 0·71–0·86) deaths per 1000 livebirths and U5MR to 1·44 
(95% UI 1·27–1·58) deaths per 1000 livebirths, and in 2019, there were as many as 1·87 million (95% UI 1·35–2·58; 
37% [95% UI 32–43]) of 5·05 million more deaths of children younger than 5 years than the survival potential 
frontier.
Interpretation Global child mortality declined by almost half between 2000 and 2019, but progress remains slower 
in neonates and 65 (32%) of 204 countries, mostly in sub-Saharan Africa and south Asia, are not on track to meet 
either SDG 3.2 target by 2030. Focused improvements in perinatal and newborn care, continued and expanded 
delivery of essential interventions such as vaccination and infection prevention, an enhanced focus on equity, 
continued focus on poverty reduction and education, and investment in strengthening health systems across the 
development spectrum have the potential to substantially improve U5MR. Given the widespread effects of 
COVID-19, considerable effort will be required to maintain and accelerate progress.
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Introduction
Under-5 mortality rate (U5MR) and neonatal mortality 
rate (NMR) are important indicators reflecting multiple 
aspects of societal wellbeing such as access to nutrition 
and food; basic infrastructure such as housing, water, 
and sanitation; education; agency; financial security; 
access to preventive and treatment health services; and 
future human capital. The UN Millennium Development 
Goals (MDGs) are credited with mobilising global action 
on child health, and manifested as an unprecedented, 
accelerated reduction in child mortality and resulted 
in 58 countries achieving the MDG 4 target of reducing 
U5MR by two-thirds.1,2 Sustainable Development Goal 
(SDG) 3.2 specifically calls to, “By 2030, end preventable 
deaths of newborn babies and children under 5 years of 
age, with all countries aiming to reduce neonatal 
mortality to at least as low as 12 per 1000 live births and 
under-5 mortality to at least as low as 25 per 1000 live 
births.”3 The SDG focus on equity was codified here in a 
shifting from relative global targets, that were mainstays 
in the MDG agenda, to absolute targets for each country.
The SDG framework aims to build on the successes of 
the MDG era, albeit with a notably broader lens in which 
health (SDG 3) is one of several goals related to healthier 
lives, wellbeing, and equity.3 Even within SDG 3, the 
SDG agenda is broader than the MDG agenda, reflecting a 
growing understanding of the intersectional nature of 
health outcomes with basic infrastructural considerations 
such as health system performance, sustainability, and 
environment. This intersectional perspective is illustrated 
in the language of initiatives such as the call from the 
UN Global Strategy for Women’s, Children’s and 
Adolescents’ Health 2016–2030 to integrate survival, 
prevention, thriving, and enabling environ ments,4 the 
Every Newborn Action Plan, the World Bank’s Global 
Financing Facility for Women, Children and Adolescents, 
The Lancet Global Health Commission on High Quality 
Health Systems, and the Countdown to 2030.5–7 Although 
this broader focus has not necessarily led to child and 
neonatal health receiving less investment in development 
assistance for health (DAH; which, for child and neonatal 
health, grew by 2·66% from 2015 to 2019 and remained 
the second largest DAH focus area in 2019), the growth in 
investment in this period was less than during the period 
between 2000 and 2015, when DAH for child and neonatal 
health increased by 314%.8
Research in context
Evidence before this study
During the Millennium Development Goal (MDG) era (2000–15), 
numerous organisations comprehensively described global 
progress in reducing child and neonatal mortality (MDG 4), 
but the early Sustainable Development Goal (SDG) period has 
seen few comparable efforts to track progress and none to date 
have attempted to quantify the preventable portion of child 
mortality (SDG 3.2). Past preventable mortality analyses have 
focused on health-care delivery, or were limited to high-income 
countries and adult populations. The most recent child mortality 
report from the UN Inter-agency Group for Child Mortality 
Estimation (UNIGME), published in 2017 for the year 2015, 
reports on all-cause mortality only. The Global Burden of 
Diseases, Injuries, and Risk Factors Study (GBD) is the only 
annual assessment of trends in all-cause mortality and cause-
specific mortality by detailed age groups for all locations with a 
population greater than 50 000 people from 1990 to the 
present that is compliant with the Guidelines for Accurate and 
Transparent Health Estimates Reporting.
Added value of this study
This analysis presents levels and trends in all-cause and cause-
specific neonatal and under-5 mortality from 2000 to 2019. 
Multiple future health scenarios for child mortality in 2030 
were constructed to represent potential trajectories, including 
the potential impacts of the COVID-19 pandemic and scenarios 
with targeted improvements in neonatal survival. Additionally, 
this study presents for the first time all-cause mortality 
estimates for granular age groups of 0–6 days, 7–27 days, 
1–5 months, 6–11 months, 12–23 months, and 2–4 years. 
SDG 3.2 explicitly prioritises ending preventable child deaths. 
Therefore, based on all-cause and cause-specific mortality 
estimates from GBD 2019, this study introduces a novel, 
reproducible, and holistic heuristic for quantifying optimal child 
survival. Within this framework are two complementary cause-
specific benchmarks: a global optimum, based on the lowest 
observed neonatal and under-5 mortality, and a survival 
potential frontier, based on stochastic frontier analysis of 
observed mortality and the Healthcare Access and Quality 
Index. The latter allows for comparing performance between 
similar countries, and specifically helps those countries with 
high mortality to establish intermediate goals.
Implications of all the available evidence
The prevention of child deaths accelerated in the MDG era. 
In the emerging SDG period, progress to prevent child deaths 
remains slowest in neonates. The study findings highlight 
regions with potential imbalances in health priorities. 
The findings can also identify causes of death with the most 
potential for reduction, and those with the greatest need for 
resources, expertise, and service delivery, or for basic research 
into prevention and treatment. To reach the SDG targets 
by 2030, policy makers must focus on balancing priorities 
between early newborn care while continuing prenatal and 
older child health initiatives. Strengthening quality health 
systems and ensuring effective investment in high-burden 
countries are imperative in order to scale up interventions. 
Equally pressing are the needs to examine within-country 
disparities and pursue integrative action on other determinants 
of health.
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There has not yet been a comprehensive assessment 
of NMR and U5MR in the SDG era. Selected publications 
assessed interim progress towards part of SDG 3.2 
or provided projections to 2030,9–13 but none have been 
comprehensive with respect to cause, age, trends, 
geo graphy, and progress towards 2030 targets. The 
comprehensive nature of the Global Burden of Diseases, 
Injuries, and Risk Factors Study (GBD) 2019 lends itself 
to a detailed analysis of levels, trends, and drivers of 
change for specific age groups, causes, and locations. 
Additionally, there has not been any previous effort, to 
our knowledge, to empirically explore the concept of 
preventable mortality in children. Although preventable 
death has been theoretically defined since the early 
2000s, the definitions has usually been through a health-
care delivery lens14,15 rather than a more holistic lens 
of preventability that might be interpreted as the 
intended wording of SDG 3.2. Furthermore, although 
the Organisation for Economic Co-operation and 
Develop ment (OECD) and Eurostat convened to provide 
a more uniform approach to interpreting avoidable 
deaths in 2019, this was with a singular focus on high-
income countries and the adult population.16
In this study, based on GBD 2019, we have three 
objectives. First, we aim to present a detailed, com-
prehensive numerical assessment of progress towards 
SDG 3.2 targets for all-cause NMR and U5MR at the 
global, regional, and national level, including a series 
of scenarios that reflect possible trends over the next 
decade including the potential effects of the COVID-19 
pandemic on young children. Second, we aim to evaluate 
comparative progress in cause-specific mortality in 
neonates and children from 2000 to 2019 to highlight 
successes and potential focus areas for improvement. 
Third, we aim to better define a holistic focus of preventable 
mortality by exploring two different measures of optimal 
child survival that can both inform global progress and 
provide a benchmark for intermediate progress evaluation 
in high-mortality settings. In so doing, this study seeks to 
meet the needs of an expansive, integrative SDG agenda, 
and to highlight the locations, age groups, and causes 
of preventable deaths, to inform policy and public health 
priorities aiming to achieve SDG 3.2. This manuscript 
was produced as part of the GBD Collaborator Network 
and in accordance with the GBD Protocol.
Methods
Overview
This study is compliant with the Guidelines for Accurate 
and Transparent Health Estimates Reporting (GATHER;17 
appendix p 9). A brief summary of each component of 
our study is described below. Extensive methodological 
details are provided in the appendix (pp 10–86).
Dimensions of the GBD study
GBD 2019 includes all-cause and cause-specific mortality 
by age and sex for 204 countries and territories, 21 of 
which were estimated at the subnational level from 1990 
to 2019, inclusive. Results in this study are presented 
only for countries and territories. All-cause mortality 
estimation covers six under-5 age groups: 0–6 days (early 
neonatal), 7–27 days (late neonatal), 1–5 months, 
6–11 months, 12–23 months, and 2–4 years. Cause-
specific mortality estimates cover four age groups: early 
neonatal, late neonatal, 28–364 days, and 1–4 years. 
Although we present all six age groups, we mainly focus 
on results for the aggregate neonatal age group 
(<28 days) and the under-5 age group (0–4 years), to 
best align with the SDG under-5 and neonatal targets. 
Similarly, we focus on the years 2000, which marks the 
establishment of the MDGs, 2015, which marks the 
establishment of the SDGs, and 2019, which is the most 
recent year of GBD estimates.
Data sources
All-cause mortality data were compiled from 203 of 
204 countries and territories ranging from the years 2000 
to 2019, for a total of 3097 location-years. Vital registration 
covered a total of 14 889 022 global under-5 deaths in this 
period (appendix p 119). A total of 8000 unique sources 
were used in estimating cause-specific mortality in 
GBD 2019. All input data sources for each component of 
analysis are available for download from the GBD 2019 
Data Input Sources Tool.
All-cause mortality estimation and assessment of 
progress towards SDG 3.2
All-cause mortality estimation closely followed the esti-
mation techniques as described for previous iterations 
of GBD,2,18,19 detailed in the appendix (p 9). Progress 
towards SDG 3.2 was assessed by examining U5MR and 
NMR in 2019. NMR is calculated as the probability of 
death between birth and 28 days and U5MR is calculated 
as the probability of death between birth and 5 years, 
and each metric is expressed as the number of deaths 
per 1000 livebirths. Aggregate mortality probabilities 
were benchmarked against the SDG thresholds of 
25 under-5 deaths per 1000 livebirths and 12 neonatal 
deaths per 1000 livebirths.
To assess relative progress across age groups, we 
compared the proportion of under-5 deaths occurring in 
each age group with the ratio of change in age-specific 
deaths to change in total under-5 deaths, for the 
periods 2000–14 and 2015–19. If progress towards 
SDG 3.2 is equal across age groups, the percentage 
contribution to progress and the percentage of total 
deaths would be equal. If the percentage of deaths is 
greater than the percentage of progress for an age group, 
then that age group is making slower progress towards 
the target.
Cause-specific mortality estimation
GBD 2019 includes 369 causes of disease and injury in a 
mutually exclusive and collectively exhaustive hierarchy 
See Online for appendix
For more on the GBD 2019 Data 
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of four levels (appendix p 87). Some conditions only 
result in fatal burden (eg, sudden infant death syn-
drome), whereas others cause only disability (eg, scabies); 
most causes have both fatal and non-fatal burden. 
Comprehensive methods for cause-specific mortality 
estimation for GBD have been previously described20 and 
are detailed in the appendix (p 35). We present most 
results at level 3 because this level is sufficiently detailed 
to reflect important cause groupings for the age groups 
presented in this analysis (eg, neonatal disorders and 
congenital birth defects), but not so detailed as to obscure 
important groupings of related conditions.
Scenarios for 2030 and beyond
U5MR and NMR were projected for six scenarios, all 
computed at the national level, up to 2030 as previously 
described.21 The first three scenarios represent the 
reference, better-than-reference, and worse-than-refer-
ence scenarios, while a fourth represents the 2030 NMR 
and U5MR in the absence of COVID-19. The remaining 
two scenarios are intended to assess outcomes for 
interventions that focus only on specific age groups, to 
evaluate if opportunity is greater in a particular age group 
than in others, and to show the limits of achievement 
when efforts do not consider distinct needs of different 
age groups. For the first of these age-specific scenarios, 
neonatal mortality is at the better-than-reference level 
and remaining under-5 mortality stays at reference level 
(neonatal scenario), and for the second, mortality for 
children aged 28–364 days is at the better-than-reference 
level and neonatal mortality stays at the reference level 
(child scenario). Many strategies to address neonatal 
mortality are fundamentally different from strategies 
targeting older infants and children, so these two 
scenarios are a broad representation of those differences.
Assessment of optimal survival potential
Our approach to inform an assessment of preventable 
mortality focused on the quantification of two different 
measures of optimal child survival based on historical 
trends. The first measure, what we term the global 
optimum, represents a universal level at which all 
additional mortality is theoretically avoidable given 
current medical knowledge and technology. This is 
analogous to the GBD method used for estimating global 
standard life expectancy. The second measure, what we 
term the survival potential frontier, aims to quantify the 
amount of mortality that is avoidable given the country’s 
level of Healthcare Access and Quality (HAQ) Index, 
thereby accounting for the differential resources available 
for health investment in different locations.
First, we calculated the global optimum for NMR and 
U5MR based on the aggregate of the lowest observed 
age-specific and cause-specific mortality rates in locations 
with populations higher than 10 000 children younger 
than 5 years (to remove noise associated with small 
numbers) between 2000 and 2019, scaling them to match 
an all-cause mortality minimum that was calculated 
using the same approach. The scaling step was added to 
account for potential differences due to small numbers 
in low-mortality settings or geographical differences in 
cause assignment that can occur between, for example, 
subcauses of neonatal disorders. This method is 
analogous to that used by GBD to calculate a global 
standard life expectancy for the purposes of calculating 
years of life lost and therefore can be interpreted to 
represent the optimum potential for reductions in child 
mortality based on current technology and health delivery 
systems.
Second, to help with developing intermediate goals and 
to evaluate progress in higher-mortality settings, we 
calculated a survival potential frontier using stochastic 
frontier analysis22 to evaluate the historical relationship 
between cause-specific neonatal and under-5 mortality 
rates and HAQ Index,23 which is an aggregate metric of 
health system per formance across all age groups 
combined. The specific formulation of the stochastic 
frontier analysis is described in detail in the appendix 
(p 70), but briefly, it uses a spline to estimate the expected 
lower bound of mortality for a given value of HAQ Index. 
Stochastic frontier analysis was chosen to quantify 
system inefficiency because of its flexibility in shape, its 
assumption of performance possibilities given static 
system inputs, and the fact that it allows for random 
effects in the model rather than assuming uniformity of 
inputs across locations.
All components of the analysis are based on 1000 draws 
of the posterior distribution of the quantity of interest 
by age, sex, location, and year. Point estimates are the 
mean of the draws, and 95% uncertainty intervals (UIs) 
represent the 2·5th and 97·5th percentiles.
Presentation of results
Results are presented by country, GBD super-region, 
and Socio-demographic Index (SDI)24 quintile. SDI is a 
composite index of income per capita, educational 
attain ment, and inverse fertility, and it is used to 
categorise countries into SDI quintiles: low SDI (ie, low 
income per capita, low educational attainment, high 
fertility), low-middle SDI, middle SDI, high-middle SDI, 
and high SDI. Full results for GBD 2019 are available 
in an online visualisation at GBD Compare and for 
download from the GBD Results Tool.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report.
Results
All-cause mortality and progress towards SDG 3.2
Over the past two decades, there has been a substantial 
decrease in global deaths of children younger than 
5 years, from 9·65 million (95% UI 9·05–10·30) in 2000, 
For more on the GBD Compare 
see https://vizhub.healthdata.
org/gbd-compare
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to 6·10 million (5·35–6·91) in 2015, and to 5·05 million 
(4·27–6·02) in 2019 (table). Of these deaths, 3·76 mil-
lion (95% UI 3·53–4·02; 39%) in 2000, 2·82 million 
(2·48–3·20; 46%) in 2015, and 2·42 million (2·06–2·86; 
48%) in 2019 occurred in neonates (aged <28 days). In 
each year analysed, the largest share of the global 
deaths of children younger than 5 years occurred in 
the sub-Saharan Africa and south Asia super-regions. 
Although U5MR declined in each successive period in 
all super-regions, the proportion of global deaths in 
children younger than 5 years in these two super-regions 
increased from 73% (7·07 million deaths [95% UI 
6·57–7·59]) in 2000 to 80% (4·04 million [3·36–4·86]) 
deaths in 2019. The share of under-5 deaths also shifted 
towards lower SDI groups in this period, with the 
proportion of under-5 deaths in the low SDI quintile 
increasing from 42% (4·01 million deaths [95% UI 
3·78–4·26]) in 2000 to 53% (2·67 million deaths 
[2·22–3·24]) in 2019.
Global U5MR and NMR both are falling short of SDG 
targets. Global U5MR declined from 71·2 (95% UI 
68·3–74·0) in 1990 to 37·1 (95% UI 33·2–41·7) deaths 
per 1000 livebirths in 2019, with corresponding changes 
in NMR from 28·0 (95% UI 26·8–29·5) in 1990 to 
17·9 (16·3–19·8) deaths per 1000 livebirths (table). The 
countries with the highest U5MR in 2019 were Central 
African Republic, Mali, and Chad, whereas Andorra, 
Singapore, and Slovenia were found to have the lowest 
U5MR. As for 2019 neonatal mortality, the highest 
rate was observed in Pakistan, followed by Mali and 
Central African Republic. The countries with the lowest 
2019 NMR were Andorra, Japan, and Singapore. U5MR 
and NMR declined in every country between 2000 
and 2019, apart from Dominica, Guam, and Northern 
Mariana Islands (appendix p 311).
We found evidence of accelerated reduction in global 
U5MR, but the largest number of deaths, as well as the 
slowest progress, occurred in the early neonatal age 
group (figure 1A, B). In all SDI quintiles, decline in NMR 
lagged behind mortality declines in other age groups 
(figure 1C, D). There is evidence of relative progress in 
neonatal mortality in the time period between 2015 
and 2019, compared with between 2000 and 2015, but 
early neonatal progress in this more recent time period is 
still slower than overall under-5 progress in low SDI 
settings (figure 1D). The proportion of neonatal death 
broadly increases as SDI increases: in 2019, in the low 
SDI quintile, 1·11 million (41%) of 2·67 million deaths in 
children younger than 5 years were neonatal deaths, and 
in the high SDI quintile 26 800 (55%) of 48 600 deaths 
in children younger than 5 years were neonatal deaths 
(appendix p 120).
In 2015, 128 (63%) of 204 countries already had an 
U5MR below the SDG 3.2 threshold of 25 deaths of 
children younger than 5 years per 1000 livebirths 
(figure 2A). By 2019, eight additional countries—Syria, 
Uzbekistan, Guatemala, Philippines, Guyana, Nauru, 
Vanuatu, and Solomon Islands—had a U5MR below 
this threshold, making a total of 136 (67%; table). 
In 2015, 126 (62%) of 204 countries had an NMR 
below the SDG 3.2 threshold of 12 neonatal deaths 
per 1000 livebirths (figure 2B). By 2019, an additional 
seven countries—Syria, Iraq, Kyrgyzstan, Uzbekistan, 
Morocco, Solomon Islands, and Vanuatu—had achieved 
an NMR below this threshold, making a total of 
133 (65%).
Under-5 mortality in each analysed year was 
somewhat higher in males than in females, although 
this difference was not statistically significant at the 
global level (appendix p 99). U5MR declined in both 
males and females in the periods between 2000 
and 2015, and between 2015 and 2019 (appendix p 99). 
The 2019 male-to-female ratio of U5MR does not 
change meaningfully with SDI; this ratio ranges 
from 1·08 in low-middle SDI to 1·18 in high SDI 
in 2019 (appendix p 99).
Figure 1: Global all-cause under-5 mortality by age, year, and SDI
(A) Under-5 deaths (in millions) for 2000–19. (B) ARC in qx for each year between 2000 and 2019. (C) Proportion 
of under-5 deaths in 2000 compared with the ratio of age-specific to total under-5 absolute change in deaths 
between 2000 and 2015 by SDI quintile. (D) Proportion of under-5 deaths in 2015 compared to ratio of 
age-specific to total under-5 absolute change in deaths between 2015 and 2019 by SDI quintile. The shaded areas 
in panels A and B represent 95% uncertainty intervals. The black line in panels C and D represents line of 
equivalence, such that points above the line indicate age and SDI groups in which change outpaces overall under-5 
mortality change and points below the line indicate age and SDI groups in which change underperforms relative to 
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Figure 2: Map of individual countries’ progress toward achieving the Sustainable Development Goals 3.2 target of (A) reducing neonatal mortality rate to the threshold of 12 neonatal deaths per 
1000 livebirths, and reducing under-5 mortality rate to the threshold of 25 under-5 deaths per 1000 livebirths (B), under the reference scenario
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Levels and trends in cause-specific mortality
The leading level 3 causes of global under-5 mortality 
in 2019 were neonatal disorders, which accounted 
for 37·3% (95% UI 35·6–38·8) of deaths in children 
younger than 5 years, followed by lower respiratory 
infections (13·3% [12·1–14·4]), diarrhoeal diseases 
(9·9% [8·3–11·6]), congenital birth defects (9·4% 
[8·0–11·8]), and malaria (7·1% [3·5–12·0]; figure 3; 
appendix p 100). Leading subcauses of neonatal 
disorders and congenital birth defects and leading 
global aetiologies of lower respiratory infections and 
diarrhoeal disease can be found in the appendix 
(pp 106, 121).
Of the 15 level 3 causes that accounted for more 
than 30 000 global under-5 deaths in 2019, the greatest 
reduction in deaths between 2000 and 2015 was 
observed in measles, which saw a –9·2% (95% UI 
–10·4 to –8·0) mean annual percentage change 
(appendix p 129). Measles was followed by protein-
energy malnutrition (–6·5% [–8·2 to –4·7]) and HIV/
AIDS (–6·0% [–6·9 to –5·0]). Among these same 15 high-
mortality causes, and for the period 2015–19, the three 
with the greatest reduction in deaths were mea sles 
(–11·3% [95% UI –13·7 to –9·0]), HIV/AIDS (–10·2% 
[–12·3 to –7·8]), and tuber culosis (–7·8 [–9·9 to –5·6]).
In 2019, causes of death varied by age, sex, and SDI 
(figure 3; appendix p 100). The most common level 3 
causes of death in children younger than 5 years were 
neonatal disorders, lower respiratory infections, and 
diarrhoeal diseases in the low SDI quintile, and neonatal 
disorders, congenital birth defects, and sudden infant 
death syndrome in the high SDI quintile (appendix 
p 100). The level 3 causes with the largest male-to-female 
ratio of mortality in the under-5 age group at the global 
level in 2019 were vascular intestinal disorders (5·99) 
and inguinal, femoral, and abdominal hernia (2·90), and 
those with the lowest ratio were gallbladder and biliary 
diseases (0·29) and pancreatitis (0·29; appendix p 100).
Scenarios for 2030 and beyond
In our reference scenario, by 2030, 154 (75%) of 
204 countries are projected to have a U5MR lower than 
the SDG threshold of 25 under-5 deaths per 1000 livebirths, 
and 139 (68%) are expected to have an NMR lower than 
the SDG threshold of 12 neonatal deaths per 1000 livebirths 
(figure 2, appendix p 93). In the better-than-reference 
Figure 3: Neonatal and remaining under-5 cause-specific mortality, by region and SDI
Values presented are cause fractions: the proportion of total age-specific deaths with a particular underlying cause of death. Causes are presented at Level 2 in the 
hierarchy, with other non-communicable diseases disaggregated to include congenital birth defects, sudden infant death syndrome, haemoglobinopathies and 
haemolytic anaemias, endocrine, metabolic, blood, and immune disorders, and urinary diseases and male infertility separately. Total under-5 mortality is split at 
28 days to include neonatal (<28 days) separately from children between 28 days and 5 years of age. SDI=Socio-demographic Index. 
Neonatal 28 days and older
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scenario, 164 (80%) countries would reach the SDG 
U5MR target, and 145 (71%) countries would reach the 
SDG NMR target (appendix p 93). In the neonatal 
scenario, 155 (76%) countries would meet the U5MR 
target, and in the child scenario, 158 (77%) countries 
would meet the U5MR target. In the counterfactual 
scenario without the COVID-19 pandemic, our results 
suggest 154 (75%) countries would have a U5MR below 
the SDG threshold and 140 (69%) countries would have 
an NMR below the SDG threshold by 2030.
Global optimum and survival potential frontier
There were an estimated 9·45 million (95% UI 
8·86–10·05) under-5 deaths more than the global 
optimum in 2000 and 4·85 million (4·09–5·80) more 
than the global optimum in 2019 (appendix p 130). These 
deaths represent 98% of all 9·65 million under-5 deaths 
in 2000 and 96% of all 5·05 million under-5 deaths 
in 2019. In 2019, only 198 000 (95% UI 169 000–224 000) 
under-5 deaths worldwide were below the global 
optimum, and of these 108 000 (93 000–122 000; 55%) 
were neonatal deaths. Based on this analysis, and on 
current technology and health delivery systems, the 
global optimum NMR is 0·80 (95% UI 0·71–0·86) and 
the global optimum U5MR is 1·44 (95% UI 1·27–1·58). 
Sex differences in mortality are similar below the global 
optimum as compared to overall mortality, with an NMR 
male-to-female ratio of 1·05 (95% UI 1·00–1·09) and a 
U5MR male-to-female ratio of 1·12 (95% UI 1·05–1·18).
16 causes of death have a global optimum of zero 
deaths and are therefore classified as 100% preventable 
by this framework. With the exceptions of exposure to 
forces of nature and conflict and terrorism, all of these 
preventable deaths are infectious conditions. If all 
countries reduced mortality to the global optimum, 
the leading level 3 global under-5 causes of death would 
be neonatal disorders; congenital birth defects; lower 
respiratory infections; sudden infant death syndrome; 
and endocrine, metabolic, blood, and immune disorders.
When looking at mortality along the spectrum of 
HAQ Index, our analysis suggests that in 2000, as many 
as 1·50 million (95% UI 1·31–1·72) neonatal deaths were 
above the survival potential frontier, accounting for 40% 
(95% UI 37–43) of 3·76 million neonatal deaths. In the 
same year, analysis suggests that 3·94 million (95% UI 
3·49–4·40) under-5 deaths were above the survival 
potential frontier: 41% (95% UI 39–43) of 9·65 million 
under-5 deaths). In 2019, the number of deaths occurring 
Figure 4: 2019 NMR and U5MR by HAQ Index at the national level
204 countries were analysed, and the colour of each point indicates the SDI quintile that the country belongs to. HAQ Index ranges from 0 (worst) to 100 (best). The survival potential frontier, global 
optimum, and SDG targets are indicated as lines on the graph. Grey shaded bands represent 95% UIs. Countries are labelled with their ISO3 country code in bold when their ratio to the survival 
potential frontier is in the highest 10% of all countries and in italics when their ratio to the survival potential frontier is in the lowest 10% of all countries. ISO3 codes and corresponding location names 
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above the survival potential frontier was smaller, but the 
fraction of the overall mortality above the survival 
potential frontier remained similar: 0·88 million (95% UI 
0·62–1·20; 36% [95% UI 30–42]) of 2·42 million neonatal 
deaths and 1·87 million (1·35–2·58; 37% [32–43]) of 
5·05 million under-5 deaths (figure 4). If all 204 countries 
were to improve performance to meet the survival 
potential frontier without changing their HAQ Index 
level from 2019, 143 (70%) would have mortality below the 
NMR SDG threshold and 149 (73%) would have mortality 
below the U5MR SDG threshold, and 43 (70%) out of 
61 countries not achieving both SDG targets would be 
from the sub-Saharan Africa super-region. The countries 
where U5MR lags the most relative to HAQ Index in 2019 
are Nigeria, Turkey, Mali, and Maldives. The countries 
where NMR lags the most relative to HAQ Index in 2019 
are Maldives, Turkey, and Azerbaijan. The countries with 
the most success at preventing under-5 mortality and 
neonatal mortality relative to their HAQ Index are Cook 
Islands, United Arab Emirates, and Tokelau (figure 4).
Global under-5 mortality above the survival potential 
frontier in 2019 consisted of 1·56 million (95% UI 
1·11–2·17; 83%) deaths due to communicable, maternal, 
neonatal, and nutritional (CMNN) diseases, 0·23 million 
(0·15–0·33; 12%) deaths due to non-communicable 
diseases, and 0·08 million (0·06–0·11; 5%) deaths due to 
injuries (appendix p 130). If all regions had mortality 
rates at their survival potential frontier levels in 2019, 
the distribution of under-5 deaths would skew slightly 
towards non-communicable diseases but would not 
fundamentally change; 2·58 million (95% UI 2·35–2·81; 
81%) deaths would be due to CMNN diseases, 
0·46 million (0·40–0·52; 15%) deaths would be due 
to non-communicable diseases, and 0·13 million 
(0·11–0·15; 4%) deaths would be due to injuries 
(appendix p 130). Of the 48 level 3 causes that were 
accountable for more than 5000 global under-5 deaths 
in 2019, those with the lowest proportion of cause-specific 
deaths above the survival potential frontier were 
sudden infant death syndrome (27% [95% UI 15–43] of 
SIDS deaths above the survival potential frontier), other 
malignant neoplasms (28% [21–36]), varicella and herpes 
zoster (29% [23–36]), and congenital birth defects 
(30% [23–37]; appendix p 94). Of the same 48 causes, 
those with the highest proportion of cause-specific deaths 
above the survival potential frontier were invasive 
non-typhoidal salmonella, other neglected tropical dis-
eases, haemoglobinopathies and haemolytic anaemias, 
and malaria, all with over 50% above the survival 
potential frontier. The leading causes of death overall 
were also those with the highest above-survival potential 
frontier mortality rates, and the rank order would remain 
similar even if all regions had cause-specific mortality 
rates at their survival potential frontier levels in 2019: 
33% of each of neonatal disorders and lower respiratory 
infections deaths were above the survival frontier 
(neonatal disorders ranked first and lower respiratory 
infections ranked second in both observed and expected), 
while 40% of diarrhoea deaths were above the frontier 




Declines of U5MR and NMR have continued to 
accelerate worldwide. Of 204 countries, our reference 
scenario suggests that, by 2030, 154 (75%) are likely to 
meet the U5MR SDG target and 139 (68%) the NMR 
SDG target. However, the concomitant findings of 
growing relative inequity and a large remaining 
proportion of preventable deaths shows there is much 
more work to be done. If every country were at the 
global optimum in 2019, global U5MR would have 
been 1·44 (95% UI 1·27–1·58) deaths per 1000 livebirths 
and NMR would have been 0·80 (95% UI 0·71–0·86) 
deaths per 1000 livebirths.
Thankfully, although children have been found to be at 
risk of developing multisystem inflammatory syn-
drome25 as result of COVID-19, they appear to be less at 
risk of severe illness and death. It is important to 
reiterate, however, how the complex, multisector 
determinants of health that substantially affect child 
survival could be negatively affected by COVID-19, an 
understanding that is likely to continue to evolve in the 
coming months and years. Risks include,26 but are not 
limited to, the potential disruption of routine perinatal 
and clinical care for children, worsened in-facility 
outcomes due to over burdened medical systems, loss of 
caretakers from the pandemic impacting child health 
and wellbeing, suspended vaccination campaigns, 
financial and economic pressures leading to food 
insecurity and malnutrition, disruption of supply chains 
leading to decreased availability of highly active 
antiretroviral therapy medications for HIV/AIDS, inter-
rupted prevention of mother-to-child transmission 
programmes, decreased malaria prevention and 
treatment, and disruption of domestic economies and 
education systems. Mitigating these risks will require 
even more focus and attention on an equilibrium 
strategy for neonatal and child health.
Our analysis suggests the need for a five-pronged 
strategy to optimise child survival in the SDG era that 
augments community-based strategies and efforts to 
address social determinants of health (eg, education, 
family planning, financial security) that proved effective 
during the MDG era. The central theme is that, to achieve 
SDG targets by 2030, investments should strive for 
equilibrium and overall system strengthening, with a 
particular focus on inequality, rather than simply shifting 
attention to individual priorities.
Comprehensive neonatal care
Neonatal deaths comprise an increasing share of global 
under-5 deaths, indicating a generalised need to improve 
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neonatal programmes along the entire SDI spectrum. 
Although not explicitly stated in SDG targets or in our 
analysis, reductions in stillbirths should also be targeted 
through comprehensive maternal and neonatal care. 
Reducing early neonatal mortality, and stillbirth 
mortality, should start with expansion of community and 
facility-based strategies targeted towards pregnancy, 
labour, delivery, and the postnatal period.27 Nepal is an 
example of a country that explicitly prioritised the 
neonatal period and integrated community and facility-
based approaches, leading to accelerated improvements 
in neonatal and under-5 mortality.28 The first step is 
encouraging and supporting facility-based delivery 
by skilled providers with the training and resources 
available to perform resuscitative efforts for women and 
neonates when needed.5 Basic activities include skin-to-
skin contact, timely breathing assistance for intrapartum 
asphyxia, chlorhexidine umbilical cord cleansing for 
sepsis prevention, and early screening for congenital 
birth defects.5 Improvements also need to be made to 
neonatal care after delivery. Advancements are needed 
for in-hospital activities such as intensive care for 
prematurity, advanced resuscitation for intrapartum 
asphyxia, full support for sepsis beyond antibiotics, 
breastfeeding education and support, and surgical care 
for neonatal emergencies and birth defects that have 
been shown to be associated with improved neonatal 
survival.27,29,30 Postnatal check-ups are also required for 
prompt diagnosis and treatment of new illnesses that 
can be life-threatening in young neonates. Crosscutting, 
longitudinal neonatal care is not possible without 
augmenting hospital infrastructure, supply chains, and 
qualified health-care workers, and must be accounted for 
in national health plans.5
Optimising health systems to scale up interventions
Providing technology and supplies alone, without 
coordinated investment in the strengthening of health 
systems, will be insufficient for achieving the SDG 
targets. Moving beyond survival is the cornerstone of 
the SDGs, which requires enabling environments, 
as outlined in the UN Global Strategy for Women’s, 
Children’s and Adolescents’ Health 2016–30 agenda.4 
Per our analysis, more than 90% of countries have the 
potential to achieve the SDG targets by optimising their 
current health systems. Efforts to counter shortages and 
retain skilled health-care workers, reinforce facility 
infrastructure and supplies including oxygen,31 develop 
and strengthen referral networks, and expand integrated 
services7 are needed to achieve access and quality of care 
for improving survival rates for children younger than 
5 years, particularly around the time of birth.27,29 Liberia is 
an example of a country that has made important 
progress in health system strengthening. Despite the 
odds of civil war and the Ebola virus epidemic, Liberia 
heavily invested in paying and supervising community 
health workers, providing medical supply chains to 
remote areas, and creating a health information system, 
leading to better survival.32
Continued investment and scale-up of community-
based initiatives
Community-based strategies such as primary health-care 
promotion and integrated management of childhood 
illness33 are an important pillar of prevention. Successful 
community activities include vaccination campaigns, 
insecticide-treated bednets for malaria, and mother-
to-child HIV/AIDS transmission prevention.34 Further 
efforts are required, however, to increase uptake and 
coverage of additional community-based activities such 
as ensuring optimal maternal nutrition and iron and folic 
acid supplementation35 (to target low birthweight and 
neural tube defects), reducing household air pollution 
and second-hand smoke, Haemophilus influenzae type B 
and pneumococcal vaccination, and access to antibiotics36 
for lower respiratory infections. Similarly, treatment 
campaigns for diarrhoea such as oral rehydra tion 
solution, zinc, and rotavirus vaccines have been 
successful, but must be accompanied by reductions in 
malnutrition and improvements in clean water and 
sanitation to achieve more than 90% reduction in rates 
of diarrhoea from the 2015 levels.37
Targeting inequity across and within countries
Relative inequity has grown over the 29 years since the 
first GBD study, with the 51 countries in the Countdown 
to 2030 initiative in sub-Saharan Africa and south Asia 
now accounting for 80% of all child mortality and 
facing stark within-country disparities.6,38 Within-country 
disparities exist throughout the SDI spectrum and are 
related to race and ethnicity, urban-rural geography, 
mother’s education, and income.34 Global and national 
achievement of SDG 3.2 will hinge on our collective 
ability to target inequality both across and within 
countries.
Progress for the countries in the Countdown to 2030 
programme is monitored by key intervention coverage 
milestones,6 but must be met with national ownership 
and effective international investment. On an inter-
national level, the World Bank’s Global Financing Facility 
is an example of a performance-based, country-led 
mechanism to strengthen health systems and multi-
sectoral approaches,6 but the promise of this programme 
has not reached countries like Central African Republic 
and Chad, which are not only the furthest from achieving 
the SDG targets with lowest key intervention coverage, 
but are also cited as receiving the least development 
assistance funding.39 These countries contrasts with 
countries like Rwanda and Bangladesh. In Rwanda, a 
revised national health policy successfully aligned 
international donors to nationally driven goals of 
comprehensive child health care and health system 
strengthening, and were associated with a dramatic 
reduction in under-5 mortality.32 In Bangladesh, the 
Articles
22 www.thelancet.com   Published online August 17, 2021   https://doi.org/10.1016/S0140-6736(21)01207-1
government partnered with domestic and international 
non-governmental organisations to target areas of the 
country most in need with delivering known inter-
ventions, performing local effectiveness research, and 
prioritising women’s empowerment.28
Peru and Brazil are examples of middle and high-middle 
SDI countries that have targeted inequity internally. Peru 
substantially reduced under-5 mortality by adopting 
the 2002 Acuerdo Nacional,28 a national health policy 
targeting extreme poverty that deployed health workers to 
impoverished communities, completed community-based 
intervention research to increase perinatal care coverage, 
and codified collective responsibility for improving health 
outcomes. Brazil sanctioned governmental conditional 
cash transfers targeting prenatal care, immunisation, 
child health check-ups, and nutritional education.28 
Although the specific solutions for targeting inequity and 
marginalised populations vary, the essential component 
is that the efforts to increase equity must be explicit, 
sustained, and universal because it is present throughout 
the world.
Prioritising research into specific causes of child mortality
Many of the leading causes of death are also the source of 
the most mortality above both the global optimum and 
the survival potential frontier, include neonatal disorders, 
congenital birth defects, sudden infant death syndrome, 
many childhood cancers, and important infections like 
lower respiratory infections, diarrhoea, and meningitis. 
These causes are prime targets for additional dedicated 
primary research on disease mechanisms for effective 
prevention, detection, and treatment. Sudden infant 
death syndrome is particularly notable as only 27% of the 
mortality burden is above the survival potential frontier, 
it is the top cause of death in older infants and children 
in the high SDI quintile, and comparatively little is 
known about its pathophysiology.
This entire analysis draws on the overall strength and 
rigour of GBD 2019, the only comprehensive analysis 
of fertility, population, mortality, and outcomes for 
specific diseases and injuries that currently exists. The 
UN Inter-agency Group for Child Mortality Estimation 
last published estimates for 201711 but has not reported 
on causes of mortality since 2015,12,40 at which time there 
was broad agreement in the top causes of death globally, 
but some important differences existed in cause 
categories that limited our ability to make direct 
comparisons.
Measuring preventable death with the intersection of 
HAQ Index and SDG targets has not been explored in 
previous literature and necessarily extends beyond the 
scope of the OECD and Eurostat taskforce that only 
focuses on adult health outcomes.16 This method is 
more holistic than previous avertable mortality frame-
works such as the Countdown to 2030 report that 
analysed only a composite coverage index of specific 
interventions, but did not measure the health system 
performance as a whole.6 Uses of our preventable 
mortality analyses include being able to identify the 
causes with the most potential for improvement 
(largest proportion above the global optimum or 
stochastic frontier analysis), the regions with potential 
imbalances in health priorities (largest ratio above 
frontier or discrepancies in ratio between neonates and 
children aged 1–59 months), causes where there are 
needs for better distributional allocation of resources, 
expertise, or delivery (those where the frontier is largely 
flat until decreasing sharply in high HAQ Index 
settings), and the causes where there is the greatest 
need for basic research into prevention and treatment 
(largest proportion below the global optimum). This 
preventable death framework thus introduces a novel, 
useful, and potentially powerful tool for developing 
comprehensive, evidence-based strategies for advancing 
child survival on multiple fronts.
Limitations
This analysis has several limitations. First, it shares the 
limitations of the overall GBD analysis,20,24 including it 
being a descriptive study; limitations on data availability 
because of reporting lags or because of disruptions 
in settings with conflict, natural disasters, or domestic 
governance crises; variable data granularity with respect 
to age, sex, and cause detail; varying quality and com-
pleteness of mortality reporting systems; and the core 
GBD assumption of each death having only a single 
underlying cause, where, clinically, there is close inter-
relatedness of many causes, especially in the very young. 
Second, our future health scenario analyses are 
benchmarked against past trends and are ecological in 
nature. This limits the ability of the analysis to be used for 
causal inference, and also means it is limited in its ability 
to capture disruptions that could arise as a consequence 
of future crises, such as the COVID-19 pandemic. Third, 
although our framework for preventable mortality is 
conceptually simple, reproducible, and a powerful tool 
for tracking context-specific progress, it is also limited by 
its inherently retrospective nature, its inability to 
parse competing risks or factors that might influence 
geographical variability, and that it does not make special 
consideration for causes like vaccine-preventable diseases 
that some experts contend are entirely preventable. 
Finally, the definition of livebirth has varied in countries 
and over time. Although our study has utilised a large 
amount of empirical data on death in the under-5 age 
groups, directly or indirectly measured, such information 
is based on potentially different definitions of livebirths, 
thus affecting the accuracy of our results. Although we do 
account for source specific biases, difference in definitions 
of livebirths as one of them, in our U5MR estimation 
process, future model development should be done to 
explicitly account for the effect of definition of livebirths 
on the accurate estimation of mortality in the under-5 
age groups.
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Future directions
Future work is required to measure and understand the 
direct (severe illness and death) and indirect (determinants 
of health) effects of COVID-19 on child mortality. First, 
this work will include collecting data on disruptions in 
basic childhood health services (eg, vaccines, integrated 
management of childhood illness, well-child visits), 
nutritional status (eg, food supply and distribution), 
perinatal health (eg, maternal and neonatal care), and 
socioeconomic indicators such as fertility, education, and 
household income. A second direction is to work towards 
an integrated framework for women’s, maternal, and 
child health because of the inherent links between the 
health of mothers and their children. Third, integrating 
information from prevention and intervention trials 
into developing future health scenarios is a priority in 
order to provide information to motivated policy makers 
as to what their most effective options might be. Fourth, 
following the momentum of the Institute for Health 
Metrics and Evaluation’s Local Burden of Disease project, 
developing increasing local estimates of cause-specific 
and age-specific disease burden is crucial to guide local 
efforts at improving survival, and assess within-country 
disparities further.
Achieving SDG 3.2 will require focus on equilibrium, 
which will involve balancing early newborn care with 
continuing prenatal and older child health initiatives, 
strengthening quality health systems, scaling up inter-
ventions, addressing within-country disparities, and 
pursuing integrative action on social determinants of 
health. All these steps forward promote the SDG agenda 
of moving beyond mere survival, for the wellbeing of 
young children worldwide.
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